These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin. Williams DJ; Hopkins S Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074 [TBL] [Abstract][Full Text] [Related]
4. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187 [TBL] [Abstract][Full Text] [Related]
5. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery. Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251 [TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group. Milsom JW; Smith DL; Corman ML; Howerton RA; Yellin AE; Luke DR Am J Surg; 1998 Dec; 176(6A Suppl):46S-52S. PubMed ID: 9935257 [TBL] [Abstract][Full Text] [Related]
7. Severe thrombocytopenia associated with alatrofloxacin. Gales BJ; Sulak LB Ann Pharmacother; 2000 Mar; 34(3):330-4. PubMed ID: 10917380 [TBL] [Abstract][Full Text] [Related]
9. Possible gatifloxacin-induced seizure. Quigley CA; Lederman JR Ann Pharmacother; 2004 Feb; 38(2):235-7. PubMed ID: 14742757 [TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans. Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin. Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system. Nakamura T; Fukuda H; Morita Y; Soumi K; Kawamura Y J Toxicol Sci; 2003 Feb; 28(1):35-45. PubMed ID: 12696183 [TBL] [Abstract][Full Text] [Related]
15. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid. Luke DR; Peterson J Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126 [TBL] [Abstract][Full Text] [Related]